Evidence map›Paper›PMID 35351715›Full record

ArticleBMJ open2022

Fighting COVID-19: a qualitative study into the lives of intensive care unit survivors in Wuhan, China.

Dong Wu, Hanyue Ding, Jiaye Lin, Meng Xiao, Jing Xie, Feng Xie, Shuyang Zhang

Abstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dong Wu *Department of Gastroenterology, Peking Union Medical College Hospital, Beijing, China.ORCID 0000-0001-9430-9874
Hanyue Ding *JC School of Public Health and Primary Care, The Chinese University of Hong Kong Faculty of Medicine, Hong Kong, Hong Kong.ORCID 0000-0001-9977-0985
Jiaye Lin *JC School of Public Health and Primary Care, The Chinese University of Hong Kong Faculty of Medicine, Hong Kong, Hong Kong.ORCID 0000-0001-8858-620X
Meng XiaoState Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China.ORCID 0000-0003-2103-7008
Jing XieState Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China.ORCID 0000-0002-9115-8895
Feng XieDepartment of Health Research Methods, McMaster University, Hamilton, Ontario, Canada fengxie@mcmaster.ca shuyangzhang103@163.com.ORCID 0000-0003-3454-6266
Shuyang ZhangState Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China fengxie@mcmaster.ca shuyangzhang103@163.com.ORCID 0000-0002-1532-0029

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe aimed to provide an insight into the life of survivors of critical COVID-19 in China.

methodsWe conducted an online survey and qualitative interviews among intensive care unit survivors of critical COVID-19 between November and December 2020 in Wuhan, China. Eligible participants were asked to complete the EQ-5D-5L and the Short Form 36-Item Survey, and invited to participate in a semistructured face-to-face interview. Descriptive analyses and phenomenological approach were adopted to analyse quantitative and qualitative data, respectively.

resultsOf 10 survivors who completed the questionnaire, 8 participated in the interview. The mean scores±SD of EuroQol-5 Dimensions-5 Level utility and EuroQol-Visual Analogue Scale were 0.88±0.15 and 80.9±14.2, respectively. The qualitative interview identified four themes, namely poor physical health, post-traumatic stress, social stigma and family support.

conclusionsCOVID-19 survivors continue fighting physical and psychological impacts. Despite strong family support, these patients are struggling with social stigma. It is a long, challenging journey to recovery for patients and society.

Indexed as

COVID-19ChinaHumansIntensive Care UnitsQualitative ResearchSurvivorsCOVID-19public healthrehabilitation medicine

Identifiers

PMID35351715
PMCPMC8960460

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.